Objectives:

  1. Explaining the building structure around innovation by establishing clear frameworks and processes helps ensure that the most promising scientific discoveries can be efficiently translated into clinical applications.
  2. Summarizing advancing cellular therapies by leveraging diverse strategies in gene editing and cell engineering to develop therapeutic cells with enhanced potential for tumor treatment.
  3. Combining clinically relevant models, biomaterials, and therapeutic cells to accelerate the path from preclinical research to effective cellular therapies

Zoom info:

Join from PC, Mac, iPad, or Android: https://uwmadison.zoom.us/s/91224356041?pwd=74bE7MijOVPsRC9U5zaBadeGCtJ977.1; Passcode:145901

Phone one-tap:

+19292056099,,91224356041# US (New York) 13017158592,,91224356041# US; +(Washington DC)

Join via audio:

+1 929 205 6099 US (New York)

+1 301 715 8592 US (Washington DC)

+1 305 224 1968 US

+1 309 205 3325 US

+1 312 626 6799 US (Chicago)

+1 646 931 3860 US

+1 564 217 2000 US

+1 669 444 9171 US

+1 669 900 6833 US (San Jose)

+1 689 278 1000 US

+1 719 359 4580 US

+1 253 205 0468 US

+1 253 215 8782 US (Tacoma)

+1 346 248 7799 US (Houston)

+1 360 209 5623 US

+1 386 347 5053 US

+1 507 473 4847 US

Webinar ID: 912 2435 6041

International numbers available: https://uwmadison.zoom.us/u/acdfJxwPay

Join from an H.323/SIP room system: H.323: 144.195.19.161 (US West) or 206.247.11.121 (US East) Meeting ID: 912 2435 6041; Passcode: 145901

SIP: [email protected]; Passcode: 145901

Session date: 
09/10/2025 - 8:00am to 9:00am CDT
Location: 
In-person and Virtually
600 Highland Ave (CSC)
G5/119
Madison, WI 53705
United States
  • 1.00 AAPA Category 1 CME
  • 1.00 ACPE Contact Hours - Pharmacist
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™
Please login or register to take this course.
Discloser List CME Internal Report
Presenter(s): 
Dr. Khalid Shah